A NEW SURGICAL OUTCOME SCORE (SOS) INCLUDING HE4, CA125 AND ASCITES VOLUME CAN PREDICT SURGICAL OUTCOME IN PRIMARY OVARIAN CANCER PATIENTS.

被引:0
|
作者
Braicu, E. [1 ]
van Gorp, T. [2 ]
Richter, R. [1 ]
Nassir, M. [3 ]
Zeillinger, R. [4 ]
Conicn, N. [5 ]
Tong, D. Cacsire Castillo [4 ]
Mahner, S. [6 ]
Vergote, I. [7 ]
Sehouli, J. [1 ]
机构
[1] Charite, Dept Gynaecol, D-13353 Berlin, Germany
[2] Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands
[3] Charite Campus Virchow, Dept Gynaecol, Berlin, Germany
[4] Med Univ Vienna, Mol Oncol Grp, Vienna, Austria
[5] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[6] Med Univ Hamburg, Clin Gynecol, Hamburg, Germany
[7] Univ Hosp KU Leuven, Dept Obstet & Gynaecol, Louvain, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
    Feng, Li-Yuan
    Liao, Sheng-bin
    Li, Li
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [32] Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
    Li-yuan Feng
    Sheng-bin Liao
    Li Li
    Journal of Ovarian Research, 13
  • [33] Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients
    Plotti, Francesco
    Guzzo, Federica
    Schiro, Teresa
    Terranova, Corrado
    Nardone, Carlo De Cicco
    Montera, Roberto
    Luvero, Daniela
    Scaletta, Giuseppe
    Lopez, Salvatore
    Capriglione, Stella
    Panici, Pierluigi Benedetti
    Angioli, Roberto
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (04) : 768 - 771
  • [34] Looking for optimized weights of CA125 and HE4 in early screening system of ovarian cancer for Korean patients
    Song, Hye-Jeong
    Nam, Kyeong-Min
    Kim, Jong-Dae
    Park, Chan-Young
    Kim, Yu-Seop
    TECHNOLOGY AND HEALTH CARE, 2016, 24 : S163 - S170
  • [35] Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis
    Wang, Jiwen
    Gao, Jia
    Yao, Hongwen
    Wu, Zongyong
    Wang, Minjie
    Qi, Jun
    TUMOR BIOLOGY, 2014, 35 (06) : 6127 - 6138
  • [36] Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer
    Tian, Yun
    Li, Xiabing
    Zhang, Hongjian
    Wang, Yaping
    Li, Hongyu
    Qin, Qiaohong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [37] The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation
    Lee, Young Joo
    Kim, Woojin
    Hong, Soomin
    Lee, Yong Jae
    Lee, Jung-Yun
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Nam, Eun Ji
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (06)
  • [38] Diagnostic value of HE4, CA125 and the ROMA index in ovarian cancer patients from a tertiary center
    Hogdall, E.
    Karlesn, M. A.
    Christensen, I. J.
    Lundvall, L.
    Engelholm, S. A.
    Nedergaard, L.
    Pedersen, Tonnes A.
    Hartwell, D.
    Hogdall, C. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 : S42 - S42
  • [39] THE EVALUATION OF PREDICTING VALUE OF HE4 AND CA125 MARKERS FOR OPTIMAL CYTOREDUCTIVE SURGERY IN OVARIAN CANCER PATIENTS
    Saffarieh, Elham
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A262 - A262
  • [40] Performance of CA125, HE4, ROMA and ultrasound sassone score in discriminating early and late stages of epithelial ovarian cancer
    Puljiz, Mario
    Marcelic, Luka
    Danolic, Damir
    Susnjar, Lucija
    Alvir, Ilija
    Banovic, Marija
    Mamic, Ivica
    Prskalo, Zvjezdana Spacir
    Mayer, Ljiljana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A309 - A310